EAN 2026: MS Copilot shows promise in monitoring disability progression in MS

Sanofi/Ad Scientiam presented an interim analysis from the ongoing MS-DETECT (NCT05816122) study, showing that Microsoft (MS) ...
Nature

Personalized progression modelling and prediction in Parkinson’s disease with a novel multi-modal graph approach

Parkinson’s disease (PD) is a complex neurological disorder characterized by dopaminergic neuron degeneration, leading to diverse motor and non-motor impairments. This variability complicates accurate ...
Nature

Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

Ductal carcinoma in situ (DCIS) represents pre-invasive breast carcinoma. In untreated cases, 25–60% DCIS progress to invasive ductal carcinoma (IDC). The challenge lies in distinguishing between ...
Multiple Sclerosis News Today

Researchers identify new therapeutic targets to combat MS progression

Researchers have identified six key proteins that could be targeted to combat MS progression, and potential drugs that could ...
ascopubs.org

Patterns of Response and Progression to Immunotherapy

Here, we aim to review the patterns of response and progression to immunotherapy, especially to immune checkpoint inhibitors. Firstly, we describe the radiographic criteria used to assess response to ...
ascopubs.org

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains? In total, 1,018 patients completed induction treatment and were randomly assigned to rituximab maintenance (n = 505) or ...